CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of end stage renal disease (ESRD)
3.4.1.2. Rise in awareness regarding hemodialysis
3.4.1.3. Rise in incidence of diabetes and hypertension
3.4.1.4. Shortage of kidneys for transplantation
3.4.2. Restraints
3.4.2.1. Risks and complications associated with dialysis
3.4.3. Opportunities
3.4.3.1. Rise in adoption of key strategy
3.4.3.2. Growth opportunities in emerging economies
CHAPTER 4: HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Equipments
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Equipments Hemodialysis Market by Type
4.3. Consumables
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Consumables Hemodialysis Market by Type
4.4. Drugs
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Services
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: HEMODIALYSIS MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Conventional Hemodialysis
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Daily Hemodialysis
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Nocturnal Hemodialysis
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: HEMODIALYSIS MARKET, BY DIALYSIS SITE
6.1. Overview
6.1.1. Market size and forecast
6.2. In-center dialysis
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Home dialysis
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
CHAPTER 7: HEMODIALYSIS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Product and Service
7.2.3. Market size and forecast, by Type
7.2.4. Market size and forecast, by Dialysis Site
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Product and Service
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Dialysis Site
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Product and Service
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Dialysis Site
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Product and Service
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Dialysis Site
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Product and Service
7.3.3. Market size and forecast, by Type
7.3.4. Market size and forecast, by Dialysis Site
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Product and Service
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Dialysis Site
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Product and Service
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Dialysis Site
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Product and Service
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Dialysis Site
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Product and Service
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Dialysis Site
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Product and Service
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Dialysis Site
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Product and Service
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Dialysis Site
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Product and Service
7.4.3. Market size and forecast, by Type
7.4.4. Market size and forecast, by Dialysis Site
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Product and Service
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Dialysis Site
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Product and Service
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Dialysis Site
7.4.5.3. Australia
7.4.5.3.1. Market size and forecast, by Product and Service
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Dialysis Site
7.4.5.4. India
7.4.5.4.1. Market size and forecast, by Product and Service
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Dialysis Site
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Product and Service
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Dialysis Site
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Product and Service
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Dialysis Site
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Product and Service
7.5.3. Market size and forecast, by Type
7.5.4. Market size and forecast, by Dialysis Site
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Product and Service
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Dialysis Site
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Product and Service
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Dialysis Site
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Product and Service
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Dialysis Site
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Product and Service
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Dialysis Site
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Baxter International Inc.
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. B. Braun Melsungen AG
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Asahi Kasei Corporation.
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. DaVita Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Nikkiso Co., Ltd
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. Nipro Corporation
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Fresenius Medical Care AG & Co. KGaA
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. Diaverum Holding AB
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Key strategic moves and developments
9.9. Rockwell Medical Technologies Inc.
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.9.7. Key strategic moves and developments
9.10. TORAY INDUSTRIES, INC.
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments
|
